We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+15.21%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+557.96%
AUM
$436B
AUM Growth
+$83.7B
Cap. Flow
+$35.4B
Cap. Flow %
8.11%
Top 10 Hldgs %
42.78%
Holding
5,681
New
461
Increased
2,914
Reduced
1,346
Closed
463

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$1.6B
2
AVGO icon
Broadcom
AVGO
+$1.11B
3
QQQ icon
Invesco QQQ Trust
QQQ
+$882M
4
JPM icon
JPMorgan Chase
JPM
+$628M
5
TSLA icon
Tesla
TSLA
+$594M

Sector Composition

Rank Sector Weight
1 Technology 19.83%
2 Financials 7.37%
3 Consumer Discretionary 6.6%
4 Communication Services 5.05%
5 Healthcare 4.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UMAC icon
4951
Unusual Machines
UMAC
$1.36B
$94 ﹤0.01%
+11
New +$69
FTHM icon
4952
Fathom Holdings
FTHM
$24M
$89 ﹤0.01%
72
IMUX icon
4953
Immunic
IMUX
$192M
$86 ﹤0.01%
12
-5,617
-100% -$51.6K
DYAI icon
4954
Dyadic International
DYAI
$36.3M
$71 ﹤0.01%
72
AFMD
4955
DELISTED
Affimed
AFMD
$66 ﹤0.01%
863
-6,653
-89% -$4.47K
MPTI.WS
4956
DELISTED
M-tron Industries Warrants
MPTI.WS
$66 ﹤0.01%
+63
New +$72
TENX icon
4957
Tenax Therapeutics
TENX
$51.6M
$63 ﹤0.01%
+11
New +$64
SOND
4958
DELISTED
Sonder
SOND
$62 ﹤0.01%
+23
New +$47
LPBBW
4959
Launch Two Acquisition Corp Warrant
LPBBW
$3.33M
$62 ﹤0.01%
390
METCB icon
4960
Ramaco Resources Class B
METCB
$412M
$57 ﹤0.01%
7
-6,276
-100% -$46.8K
UUP icon
4961
Invesco DB US Dollar Index Bullish Fund
UUP
$414M
$54 ﹤0.01%
2
IGSB icon
4962
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$23.3B
$53 ﹤0.01%
1
BDSX icon
4963
Biodesix
BDSX
$262M
$51 ﹤0.01%
9
-2,763
-100% -$22.3K
IGLB icon
4964
iShares 10+ Year Investment Grade Corporate Bond ETF
IGLB
$2.78B
$50 ﹤0.01%
1
MODV
4965
DELISTED
ModivCare
MODV
$43 ﹤0.01%
14
-12,401
-100% -$22.8K
TAYD icon
4966
Taylor Devices
TAYD
$166M
$43 ﹤0.01%
1
-3,150
-100% -$112K
VHC icon
4967
VirnetX Holding Corp
VHC
$60.1M
$43 ﹤0.01%
4
NXU
4968
DELISTED
Nxu, Inc. Class A Common Stock
NXU
$43 ﹤0.01%
+390
New +$1.01K
XTKG
4969
DELISTED
X3 Holdings Co., Ltd. Class A Ordinary Shares
XTKG
0
CARM
4970
DELISTED
Carisma Therapeutics
CARM
$39 ﹤0.01%
100
-549,205
-100% -$147K
PRPH
4971
DELISTED
ProPhase Labs
PRPH
$39 ﹤0.01%
10
-1,247
-99% -$4.17K
QNCX icon
4972
Quince Therapeutics
QNCX
$30M
0
TS icon
4973
Tenaris
TS
$27.4B
$37 ﹤0.01%
1
-35,274
-100% -$1.21M
LUCK
4974
Lucky Strike Entertainment
LUCK
$893M
$37 ﹤0.01%
4
-4,628
-100% -$41.8K
CNSY
4975
Cerenome, Inc. Common Stock
CNSY
$26.4M
$36 ﹤0.01%
4
-38
-90% -$497

Similar funds

Barclays's Q2 2025 Portfolio in Review

As of Q2 2025, Barclays held 5,681 positions worth $436B, up 24% from $353B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Barclays deployed $35.4B of net new capital in Q2 2025, opening 461 new positions and adding to 2,914 existing holdings. Its largest new stake was iShares MBS ETF: 4,310,047 shares worth $405M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Honeywell, an estimated $1.54B trimmed.

  • Barclays's largest Q2 2025 buy was iShares MBS ETF: 4,310,047 shares worth $405M.
  • Barclays added most to NVIDIA in Q2 2025, an estimated $1.6B increase.
  • Barclays's biggest Q2 2025 reduction was Honeywell, cutting an estimated $1.54B.
  • Barclays fully exited Berry Global Group, Inc. in Q2 2025, selling an estimated $173M.
  • Barclays's ten largest holdings make up 43% of its $436B portfolio in Q2 2025.
  • Barclays opened 461 new positions and closed 463 in Q2 2025.
  • Barclays's portfolio value rose 24% quarter-over-quarter to $436B.

Based on Barclays's 13F filing for Q2 2025, filed 13 Aug 2025.